Enzymes and genes used for producing vanillin

ABSTRACT

Enzymes obtained from Amycolatopsis sp. HR167 (DSMZ 9992) can be used for synthesizing vanillin from ferulic acid. DNA which codes for these enzymes and host cells which are transformed using this DNA can be used for producing vanillin.

[0001] The present invention relates to enzymes for preparing vanillin from ferulic acid, the use thereof in preparing vanillin, DNA coding for said enzymes and host cells transformed with said DNA.

[0002] EP A 0 583 687 describes the preparation of substituted methoxyphenols using a new Pseudomonas sp. The starting material here is eugenol and the final products obtained are ferulic acid, vanillic acid, coniferyl alcohol and coniferyl aldehyde.

[0003] Possibilities for ferulic acid biotransformation have been published in “Biocatalytic transformation of ferulic acid: an abundant aromatic natural product; J. Ind. Microbiol. 15:457-471”.

[0004] The Journal of Bioscience and Bioengineering, Vol. 88, No.1, 103-106 (1999) likewise describes biotransformation of ferulic acid to vanillin.

[0005] EP-A 0 845 532 described the Pseudomonas sp. genes and enzymes for coniferyl alcohol, coniferyl aldehyde, ferulic acid, vanillin and vanillic acid synthesis.

[0006] WO 97/35999, J. Biol. Chem. 273:4163-4170 and Microbiology 144:1397-1405 describe the enzymes for converting trans-ferulic acid to trans-feruloyl-SCoA ester and further to vanillin and the Pseudomonas fluorescens gene for hydrolyzing said ester.

[0007] EP A 97 110 010 and Appl. Microbiol. Biotechnol. 51:456-461 describe a process for producing vanillin using Streptomyces setonii.

[0008] DE A 198 50 242 describes the construction of production strains for preparing substituted phenols by specific inactivation of genes of eugenol and ferulic acid catabolism.

[0009] DE-A 195 32 317 describes fermentative vanillin production from ferulic acid with high yields using Amycolatopsis sp.

[0010] Amycolatopsis sp. HR167 (DSMZ 9992) enzymes for vanillin synthesis from ferulic acid have been found.

[0011] The enzymes have been isolated and characterized.

[0012] Enzymes of the invention are those which exert at least feruloyl-CoA synthetase activity and comprise amino acid sequences which are at least 70% identical, preferably 80% identical, particularly preferably 90% identical, very particularly preferably 95% identical, to a sequence according to SEQ ID NO: 2 over a distance of at least 20, preferably at least 25, particularly preferably at least 30, consecutive amino acids and very particularly preferably over the entire lengths thereof, and those which exert enoyl-CoA hydratase/aldolase activity and comprise amino acid sequences which are at least 70% identical, preferably 80% identical, particularly preferably 90% identical, very particularly preferably 95% identical, to a sequence according to SEQ ID NO: 3 over a distance of at least 20, preferably at least 25, particularly preferably at least 30, consecutive amino acids and very particularly preferably over the entire lengths thereof.

[0013] The degree of identity of the amino acid sequences is preferably determined with the aid of the GAP program of the GCG program package, version 9.1, with standard settings (Nucleic Acids Research 12, 387 (1984).

[0014] The term “enzymes”, as used herein, refers to proteins characterized by the above-described functionality. It includes amino acid chains which may be modified either by natural processes such as posttranslational processing or by chemical processes known per se. Such modifications may occur at various sites and several times in a polypeptide, for example on the peptide backbone, on amino acid side chains, and on the amino and/or on the carboxy terminus. They include, for example, acetylations, acylations, ADP ribosylations, amidations, covalent linkages to flavins, heme moieties, nucleotides or nucleotide derivatives, lipids or lipid derivatives or phosphatidylinositol, cyclizations, disulfide bond formations, demethylations, cystine formations, formylations, gamma-carboxylations, glycosylations, hydroxylations, iodizations, methylations, myristoylations, oxidations, proteolytic processings, phosphorylations, selenoylations and tRNA-mediated additions of amino acids.

[0015] The enzymes of the invention may be present in the form of “mature” proteins or as parts of larger proteins, for example as fusion proteins. Furthermore, they may have secretion or leader sequences, pro sequences, sequences enabling easy purification, such as multiple histidine residues, or additional stabilizing amino acids.

[0016] Enzymes exerting activity which is increased or reduced by 50%, compared to the feruloyl-CoA synthetase and enoyl-CoA hydratase/aldolase which comprise the inventive enzymes having an amino acid sequence according to SEQ ID NO: 2 and SEQ ID NO: 3, are considered as still being in accordance with the invention.

[0017] Compared to the corresponding region of naturally occurring feruloyl-CoA synthetases and enoyl-CoA hydratases/aldolases, the enzymes of the invention may have deletions or amino acid substitutions, as long as they still exert at least one biological activity of the complete enzymes. Conservative substitutions are preferred. Such conservative substitutions include variations, with an amino acid being replaced with another amino acid from the following group:

[0018] 1. small aliphatic, nonpolar or slightly polar residues: Ala, Ser, Thr, Pro and Gly;

[0019] 2. polar, negatively charged residues and amides thereof: Asp, Asn, Glu and Gln;

[0020] 3. polar, positively charged residues: His, Arg and Lys;

[0021] 4. large aliphatic, nonpolar residues: Met, Leu, Ile, Val and Cys; and

[0022] 5. aromatic residues: Phe, Tyr and Trp.

[0023] The following list depicts preferred conservative substitutions: Original residue Substitution Ala Gly, Ser Arg Lys Asn Gln, His Asp Glu Cys Ser Gln Asn Glu Asp Gly Ala, Pro His Asn, Gln Ile Leu, Val Leu Ile, Val Lys Arg, Gln, Glu Met Leu, Tyr, Ile Phe Met, Leu, Tyr Ser Thr Thr Ser Trp Tyr Tyr Trp, Phe Val Ile, Leu

[0024] The present invention also relates to nucleic acids which code for the enzymes of the invention.

[0025] The nucleic acids of the invention are in particular single-stranded or double-stranded deoxyribonucleic acids (DNA) or ribonucleic acids (RNA). Preferred embodiments are genomic DNA fragments which can contain introns, and cDNAs.

[0026] Preferred embodiments of the nucleic acids of the invention are cDNAs having a nucleotide acid sequence according to SEQ ID NO 1.

[0027] The present invention likewise comprises nucleic acids hybridizing to the sequences according to SEQ ID NO: 1 under stringent conditions.

[0028] The term “hybridizing”, as used herein, describes the process in which a single-stranded nucleic acid molecule forms base pairs with a complementary strand. In this way, it is possible, on the basis of the sequence information disclosed herein, for example, to isolate DNA fragments from other organisms, which code for enzymes having feruloyl-CoA synthetase and/or enoyl-CoA hydratase/aldolase activity.

[0029] The present invention furthermore comprises nucleic acids which are at least 70%, preferably 80%, particularly preferably 90%, very particularly preferably 95%, identical to a sequence according to SEQ ID NO: 1 over a distance of at least 20, preferably at least 25, particularly preferably at least 30, consecutive nucleotides and very particularly preferably over the entire lengths thereof.

[0030] The degree of identity of the nucleic acid sequences is preferably determined with the aid of the GAP program of the GCG program package, version 9.1, with standard settings (Nucleic Acids Research 12, 387 (1984).

[0031] The present invention furthermore relates to DNA constructs comprising a nucleic acid of the invention and a heterologous promoter.

[0032] The term “heterologous promoter”, as used herein, refers to a promoter having properties different from those of the promoter which controls expression of the relevant gene in the original organism. The term “promoter”, as used herein, generally refers to expression control sequences.

[0033] The selection of heterologous promoters depends on whether prokaryotic or eukaryotic cells or cell-free systems are used for expression. Examples of heterologous promoters are the lac system, the trp system, the main operator and promoter regions of phage lambda, the control regions of the fd coat protein, the 3-phosphoglycerate kinase promoter, the early or late SV40, adenovirus or cytomegalovirus promoter, the acidic phosphatase promoter and the yeast mating factor α promoter.

[0034] The invention furthermore relates to vectors containing a nucleic acid of the invention or a DNA construct of the invention. Vectors which may be used are all plasmids, phasmids, cosmids, YACs or artificial chromosomes used in molecular-biological laboratories.

[0035] The present invention also relates to host cells containing a nucleic acid of the invention, a DNA construct of the invention or a vector of the invention.

[0036] The term “host cell”, as used herein, refers to cells not naturally containing the nucleic acids of the invention.

[0037] Suitable host cells are both prokaryotic cells such as bacteria of the genera Bacillus, Lactococcus, Lactobacillus, Pseudomonas, Streptomyces, Streptococcus, Staphylococcus, preferably E. coli, and eukaryotic cells such as yeasts of the genera Saccharomyces, Candida, Pichia, filamentous fungi of the genera Aspergillus, Penicillium, or plant cells or whole plants of various genera such as Nicotiana, Solanum, Brassica, Beta, Capsicum and Vanilla.

[0038] The present invention furthermore relates to methods for preparing the enzymes of the invention. To prepare the enzymes encoded by the nucleic acids of the invention, host cells containing one of the nucleic acids of the invention can be cultured under suitable conditions. In this connection, the nucleic acid to be expressed may be adapted to the codon usage of the host cells. The desired enzymes may then be isolated from the cells or the culture medium in the usual manner. The enzymes may also be produced in in-vitro systems.

[0039] A rapid method for isolating the enzymes of the invention, which are synthesized by host cells using a nucleic acid of the invention, starts with expression of a fusion protein, it being possible to affinity-purify the fusion partner in a simple manner. The fusion partner may be, for example, glutathione S-transferase. The fusion protein may then be purified on a glutathione affinity column. The fusion partner can be removed by partial proteolytic cleavage, for example, of linkers between the fusion partner and the inventive polypeptide to be purified. The linker may be designed such that it includes target amino acids such as arginine and lysine residues which define trypsin cleavage sites. In order to generate such linkers, standard cloning methods using oligonucleotides may be applied.

[0040] Further possible purification methods are based on preparative electrophoresis, FPLC, HPLC (applying, for example, gel filtration, reverse phase or slightly hydrophobic columns), gel filtration, differential precipitation, ion exchange chromatography and affinity chromatography.

[0041] The terms “isolation and purification”, as used herein, mean that the enzymes of the invention are removed from other proteins or other macromolecules of the cells. Preferably, a composition containing the enzymes of the invention is at least 10-fold and particularly preferably at least 100-fold concentrated with respect to the protein content, compared to a preparation from the host cells.

[0042] The enzymes of the invention may also be affinity-purified without a fusion partner with the aid of antibodies binding to said enzymes.

[0043] The present invention further relates to methods for preparing the nucleic acids of the invention. The nucleic acids of the invention may be prepared in the usual manner. It is possible, for example, to chemically synthesize the nucleic acid molecules completely. It is also possible to chemically synthesize only short pieces of the sequences of the invention and to label such oligonucleotides radioactively or with a fluorescent dye. The labeled oligonucleotides can be used for screening cDNA banks, prepared starting from bacteria or plant mRNA, or genomic banks, prepared starting from genomic bacteria or plant DNA. Clones to which the labeled oligonucleotides hybridize are selected for isolating the DNA in question. After characterizing the isolated DNA, the nucleic acids of the invention are obtained in a simple manner.

[0044] The nucleic acids of the invention may also be prepared by means of PCR methods using chemically synthesized oligonucleotides.

[0045] The term “oligonucleotide(s)”, as used herein, means DNA molecules consisting of 10 to 50 nucleotides, preferably 15 to 30 nucleotides. They are chemically synthesized and may be used as probes.

[0046] Likewise, the invention relates to the individual preparation steps of preparing vanillin from ferulic acid:

[0047] a) the method for preparing feruloyl-coenzymeA from ferulic acid, which takes place in the presence of feruloyl-CoA synthetase;

[0048] b) the method for preparing 4-hydroxy-3-methoxyphenyl-β-hydroxypropionyl-coenzymeA from feruloyl-coenzymeA, which takes place in the presence of enoyl-CoA hydratase/aldolase;

[0049] c) the method for preparing vanillin from 4-hydroxy-3-methoxyphenyl-β-hydroxypropionyl-coenzymeA, which takes place in the presence of enoyl-CoA hydratase/aldolase.

[0050] The abovementioned preparation methods are based on said isolated enzymes or cell extracts containing said enzymes.

[0051] Likewise, the invention relates to preparation methods based on host cells containing the abovementioned genes and host cells transformed with said DNA or said vectors.

[0052] Ferulic acid is the preferred substrate for preparing vanillin using the abovementioned host cells. However, the addition of further substrates or even the replacement of ferulic acid with another substrate may be possible.

[0053] Nutrient media for the host cells used according to the invention which may be considered are synthetic, semi-synthetic and complex culture media. These may contain carbon-containing and nitrogen-containing compounds, inorganic salts, where appropriate trace elements and vitamins.

[0054] Carbon-containing compounds which may be considered are carbohydrates, hydrocarbons and organic base chemicals. Examples of compounds which may be used preferably are sugars, alcohols or sugar alcohols, organic acids and complex mixtures.

[0055] The preferred sugar used is glucose. Organic acids which may be used preferably are citric acid or acetic acid. The complex mixtures include, for example, malt extract, yeast extract, casein and casein hydrolysate.

[0056] Nitrogen-containing substrates which may be considered are inorganic compounds. Examples of these are nitrates and ammonium salts. Likewise it is possible to use organic nitrogen sources. These include yeast extract, soya flour, casein, casein hydrolysate and corn steep liquor.

[0057] Examples of inorganic salts which may be used are sulfates, nitrates, chlorides, carbonates and phosphates. The metals contained in said salts are preferably sodium, potassium, magnesium, manganese, calcium, zinc and iron.

[0058] The culturing temperature is preferably in the range from 5 to 100° C. Particular preference is given to the range from 15 to 60° C. and highest preference is given to 22 to 45° C. The pH of the medium is preferably from 2 to 12. Particular preference is given to the range from 4 to 8.

[0059] In principle, it is possible to use all bioreactors known to the skilled worker for carrying out the method of the invention. Preferably, consideration is given to all apparatuses suitable for submerged processes, i.e. it is possible to use according to the invention vessels without or with a mechanical mixing device. The former include, for example, shaking apparatuses, bubble-column reactors and loop reactors. The latter preferably include all known apparatuses with stirrers of any design.

[0060] The method of the invention may be carried out continuously or batchwise. The fermentation time until a maximum amount of product is reached depends on the specific type of host cells used. In principle, however, the fermentation times are between 2 and 200 hours.

[0061] The invention makes it possible to prepare vanillin from ferulic acid using any host cells.

EXAMPLES

[0062] Procedure:

[0063] After NMG mutagenesis, mutants defective in individual steps of ferulic acid catabolism were obtained from the ferulic acid-utilizing Pseudomonas sp. strain HR199. Starting from partially EcoRI-digested total DNA of the Amycolatopsis sp. wild type HR167, a gene bank was constructed in cosmid pVK100which has a broad host spectrum and is also stably replicated in pseudomonads. After packaging into phage-λ particles, the hybrid cosmids were transduced to Escherichia coli S17-1. The gene bank comprised 5000 recombinant E. coli S17-1 clones. The hybrid cosmid of each clone was conjugatively transferred into two ferulic acid-negative mutants (mutants SK6167 and SK6202) of Pseudomonas sp. strain HR199 and checked for possible complementation capability. The hybrid cosmids pVK1-1, pVK12-1, pVK15-1 were identified in the process, which made it possible for mutants SK6167 and SK6202 to utilize ferulic acid again.

[0064] It was possible to attribute the complementing property of plasmids pVK1-1, pVK12-1, pVK15-1 to a 20 kbp EcoRI fragment (E200). The genes fcs and ech which code for feruloyl-CoA synthetase and enoyl-CoA hydratase/aldolase were localized on a 4 kbp PstI subfragment (P40).

[0065] Expression of these genes made it possible for recombinant E. coli XL1-Blue strains to convert ferulic acid to vanillin.

[0066] Material and Methods:

[0067] Bacterial growth conditions. Escherichia coli strains were cultivated at 37° C. in Luria-Bertani (LB) or M9 mineral medium (Sambrook, J. E. F. Fritsch and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.). Pseudomonas sp. strains were cultivated at 30° C. in nutrient broth (NB, 0.8%, wt/vol) or in mineral medium (MM) (Schlegel, H. G. et al. 1961. Arch. Mikrobiol. 38:209-222). Amycolatopsis sp. strains were cultivated at 42° C. in yeast extract-malt extract-glucose medium (YMG, yeast extract 0.4%, wt/vol, malt extract 1%, wt/vol, glucose 0.4%, wt/vol, pH 7.2). Ferulic acid, vanillin, vanillic acid and protocatechuic acid were dissolved in dimethyl sulfoxide and added to the respective medium at a final concentration of 0.1% (wt/vol). Tetracycline and kanamycin were used for cultivation of Pseudomonas sp. transconjugants at final concentrations of 25 μg/ml and 300 μg/ml, respectively.

[0068] Nitrosoguanidine mutagenesis. Nitrosoguanidine mutagenesis of Pseudomonas sp. HR199 was carried out with modifications according to Miller (Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.). Potassium phosphate (KP) buffer (100 mM, pH 7.0) was used instead of citrate buffer. The final concentration of N-methyl-N′-nitro-N-nitroso-guanidine was 200 μg/ml. The mutants obtained were screened for loss of the ability to utilize ferulic acid as growth substrates.

[0069] Qualitative and quantitative detection of metabolic intermediates in culture supernatants. Culture supernatants were analyzed by means of high-pressure liquid chromatography (Knauer HPLC) directly or following dilution with double-distilled H_(a)O. Chromatography was carried out on Nucleosil-100 C18 (7 μm, 250×4 mm). The solvent used was 0.1% (vol/vol) formic acid and acetonitrile. The gradient used for eluting the substances was as follows.

[0070] 00:00-06:30--->26% acetonitrile

[0071] 06:30-08:00--->100% acetonitrile

[0072] 08:00-12:00--->100% acetonitrile

[0073] 12:00-13:00--->26% acetonitrile

[0074] 13:00-18:00--->26% acetonitrile

[0075] Determination of feruloyl-CoA synthetase (ferulic-acid thiokinase) activity. FCS activity was determined at 30° C. by an optical enzymic assay, modified according to Zenk et al. (Zenk et al. 1980. Anal. Biochem. 101:182-187). The reaction mixture of 1 ml in volume contained 0.09 mmol of potassium phosphate (pH 7.0), 2.1 mmol of MgCl₂, 0.7 mmol of ferulic acid, 2 mmol of ATP, 0.4 mmol of coenzyme A and enzyme solution. Formation of the CoA ester from ferulic acid was monitored at λ=345 nm (ε=10 cm²/mmol). The enzyme activity was given in units (U), with 1 U corresponding to the amount of enzyme which converts 1 mmol of substrate per minute. The protein concentrations in the samples were determined according to Lowry et al. (Lowry, O. H., N. J. Rosebrough, A. L. Farr and R. J. Randall. 1951. J. Biol. Chem. 193:265-275).

[0076] Electrophoretic methods. Protein-containing extracts were fractionated under denaturing conditions in 11.5% (wt/vol) polyacrylamide gels according to the method of Laemmli (Laemmli, U. K. 1970. Nature (London) 227:680-685). Serva Blue R was used for unspecific protein staining.

[0077] Transfer of proteins from polyacrylamide gels to PVDF membranes. Proteins were transferred from SDS polyacrylamide gels to PVDF membranes (Waters-Millipore, Bedford, Mass., USA) with the aid of a semi dry-fast blot apparatus (B32/33, Biometra, Göttingen, Germany) according to the manufacturer's instructions.

[0078] Determination of N-terminal amino acid sequences. N-terminal amino acid sequences were determined with the aid of a protein peptide sequencer (type 477 A, Applied Biosystems, Foster City, USA) and a PTH analyzer according to the manufacturer's instructions.

[0079] Isolation and manipulation of DNA. Genomic DNA was isolated according to the method of Marmur (Marmur, J. 1961. J. Mol. Biol. 3:208-218). Plasmid DNA and DNA restriction fragments were isolated and analyzed, hybrid cosmids were packaged into phage-λ particles and E. coli were transduced according to standard methods (Sambrook, J., E. F. Fritsch and T. Maniatis. 1989. Molecular cloning: a laboratory manual. 2nd Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.).

[0080] Transfer of DNA. Competent Escherichia coli cells were prepared and transformed according to the method of Hanahan (Hanahan, D. 1983. J. Mol. Biol. 166:557-580). Conjugative plasmid transfer between plasmid-carrying Escherichia coli S17-1 strains (donor) and Pseudomonas sp. strains (recipient) was carried out on NB agar plates according to the method of Friedrich et al. (Friedrich, B. et al. 1981. J. Bacteriol. 147:198-205), or by a “mini complementation method” on MM agar plates containing 0.5% (wt/vol) gluconate as carbon source and 25 μg/ml tetracycline or 300 μg/ml kanamycin. Recipient cells were applied in an inoculation streak in one direction. After 5 min, donor strain cells were applied in inoculation streaks, crossing the recipient inoculation streak. After incubation for 48 h at 30° C., the transconjugants were growing directly behind the crossing-over point, whereas neither donor nor recipient strain was able to grow.

[0081] DNA sequencing. Nucleotide sequences were determined according to the dideoxy chain termination method of Sanger et al. (Sanger et al. 1977. Proc. Natl. Acad. Sci. USA 74:5463-5467) using an LI-COR DNA sequencer model 4000L (LI-COR Inc., Biotechnology Division, Lincoln, Nebr., USA) and a Thermo Sequenase fluorescent labeled primer cycle sequencing kit with 7-deaza-dGTP (Amersham Life Science, Amersham International pls, Little Chalfont, Buckinghamshire, England), in each case according to the manufacturer's protocol.

[0082] Both DNA strands were sequenced with the aid of synthetic oligonucleotides according to the primer hopping strategy of Strauss et al. (Strauss, E. C. et al. 1986. Anal. Biochem. 154:353-360).

[0083] Chemicals, biochemicals and enzymes. Restriction enzymes, T4 DNA ligase, lambda DNA and enzymes and substrates for the optical-enzymic assays were obtained from C. F. Boehringer & Söhne (Mannheim, Germany) or from GIBCO/BRL (Eggenstein, Germany). Type NA agarose was [lacuna] from Pharmacia-LKB (Uppsala, Sweden). All other chemicals were from Haarmann & Reimer (Holzminden, Germany), E. Merck A G (Darmstadt, Germany), Fluka Chemie (Buchs, Switzerland), Serva Feinbiochemica (Heidelberg, Germany) or Sigma Chemie (Deisenhofen, Germany).

Example 1

[0084] Isolation of Pseudomonas sp. Strain HR199 Mutants Defective in Ferulic Acid Catabolism

[0085] The Pseudomonas sp. strain HR199 was subjected to nitrosoguanidine mutagenesis with the aim of isolating mutants defective in ferulic acid catabolism. The mutants obtained were classified with respect to their ability to utilize ferulic acid and vanillin as carbon and energy sources. The mutants SK6167 and SK6202 were no longer capable of utilizing ferulic acid as carbon and energy source but were able, like the wild type, to utilize vanillin. The abovementioned mutants were used as recipients of the Amycolatopsis sp. HR167 gene bank in conjugation experiments.

Example 2

[0086] Construction of an Amycolatopsis sp. HR167 Gene Bank in Cosmid Vector pVK100

[0087] Genomic DNA of Amycolatopsis strain sp. HR167 was isolated and subjected to a partial restriction digest with EcoRI. The DNA preparation thus obtained was ligated with EcoRI-cut vector pVK100. DNA concentrations were relatively high in order to force the formation of concatemeric ligation products. The ligation mixtures were packaged into phage-λ particles which were then used to transduce E. coli S17-1. Transductants were selected on tetracycline-containing LB agar plates. In this way 5000 transductants containing different hybrid cosmids were obtained.

Example 3

[0088] Identification of Hybrid Cosmids Harboring Essential Genes of Ferulic Acid Catabolism

[0089] The hybrid cosmids of the 5000 transductants were conjugatively transferred into mutants SK6167 and SK6202 by a mini complementation method. The transconjugants obtained were analyzed on MM plates containing ferulic acid with respect to their ability to grow again on ferulic acid (complementation of mutants). The mutants SK6167 and SK6202 were complemented by obtaining hybrid cosmids pVK1-1, pVK12-1, pVK15-1. It was possible to attribute the complementing property to a 20 kbp EcoRI fragment.

Example 4

[0090] Analysis of the 20 kbp EcoRI Fragment (E200) of Hybrid Cosmid pVK1-1

[0091] The E200 fragment was preparatively isolated from the EcoRI-digested hybrid cosmid pVK1-1 and ligated with EcoRI-digested pBluescript SK− DNA. The ligation mixture was used to transform E. coli XL1-Blue. After “blue/white” selection on LB-Tc-Amp agar plates containing X-Gal and IPTG, “white” transformants were obtained whose pSKE200 hybrid plasmid contained the cloned E200 fragment. With the aid of this plasmid and by using different restriction enzymes, a physical map of fragment E200 was produced.

[0092] The region complementing the mutants SK6167 and SK6202 was narrowed down to a 4 kbp PstI subfragment (P40) by cloning subfragments of E200 into vectors pVK101 and pMP92, both of which have a broad host spectrum and are also stable in pseudomonads, and by subsequent transfer via conjugation into mutants SK6167 and SK6202. After cloning said fragment into pBluescript SK−, the nucleotide sequence was determined, and the genes fcs and ech which code for feruloyl-CoA synthetase and enoyl-CoA hydratase/aldolase were identified in the process. The fcs gene product of 491 amino acids was 35% identical (over a range of 491 amino acids) to the fadD13 gene product from Mycobacterium tuberculosis (Cole et al. 1998. Nature 393:537-544). The ech gene product of 287 amino acids was 62% identical (over a range of 267 amino acids) to p-hydroxycinnamoyl-CoA hydratase/lyase from Pseudomonas fluorescens (Gasson et al. 1998. Metabolism of ferulic acid to vanillin. J. Biol. Chem. 273:4163-4170).

Example 5

[0093] Heterologous Expression of Ferulic Acid Catabolism Genes from Amycolatopsis sp. HR167 in Escherichia coli

[0094] The 4 kbp PstI subfragment (P40) was preparatively isolated from the PstI-digested pSKE200 hybrid plasmid and ligated with PstI-digested pBluescript SK− DNA. The ligation mixture was used to transform E. coli XL1-Blue. After “blue/white” selection on LB-Tc-Amp agar plates containing X-Gal and isopropyl-β-D-thiogalactopyranoside (IPTG), “white” transformants were obtained whose pSKP40 hybrid plasmid contained the cloned P40 fragment. The recombinant E. coli XL1-Blue strains had a feruloyl-CoA-synthetase activity of 0.54 U/mg of protein.

Example 6

[0095] Biotransformation of ferulic acid to vanillin using resting cells of the recombinant Escherichia coli strain XL1-Blue (pSKP40) which expresses the fcs and ech genes from Amycolatopsis sp. HR167.

[0096]E. coli XL1-Blue (pSKP40) was cultured in 50 ml of LB medium containing 12.5 μg/ml tetracycline and 100 μg/ml ampicillin at 37° C. for 24 h. The cells were harvested under sterile conditions, washed with 100 mM potassium phosphate buffer (pH 7.0) and resuspended in 50 ml of HR-MM containing 5.15 mM ferulic acid. 2.3 mM vanillin were detectable in the culture supernatant after 6 h, 2.8 mM after 8 h and 3.1 mM after 23 h.

[0097] Notes Regarding the Sequence Listing:

[0098] SEQ ID NO: 1 depicts the nucleotide and amino acid sequences of the feruloyl-CoA-synthetase and enoyl-CoA-hydratase/aldolase cDNAs. SEQ ID NO: 2 and SEQ ID NO: 3 further depict the amino acid sequences of the proteins derived from the feruloyl-CoA-synthetase and enoyl-CoA-hydratase/aldolase cDNA sequences.

1 3 1 2520 DNA Amycolatopsis sp. RBS (114)..(117) 1 tgctggccgc gctcggcggg ctggtcgccg ccgtcctgaa cggcgcgccg gccatctgac 60 cttgacgccg tcggcccgct cttgctatcc ctatatcaga actactgata tagggagcga 120 tgc atg agc aca gcg gtc ggc aac ggg cgg gtc cgg acg gag ccg tgg 168 Met Ser Thr Ala Val Gly Asn Gly Arg Val Arg Thr Glu Pro Trp 1 5 10 15 ggc gag acg gtt ctg gtg gag ttc gac gaa ggc atc gcc tgg gtc atg 216 Gly Glu Thr Val Leu Val Glu Phe Asp Glu Gly Ile Ala Trp Val Met 20 25 30 ctc aac cgg ccg gac aag cgc aac gcc atg aac ccc acc ctg aac gac 264 Leu Asn Arg Pro Asp Lys Arg Asn Ala Met Asn Pro Thr Leu Asn Asp 35 40 45 gag atg gtg cgg gtg ctg gac cac ctg gag ggc gac gac cgc tgc cga 312 Glu Met Val Arg Val Leu Asp His Leu Glu Gly Asp Asp Arg Cys Arg 50 55 60 gtg ctg gtg ctg acc ggc gcg ggc gag tcg ttc tcc gcg ggc atg gac 360 Val Leu Val Leu Thr Gly Ala Gly Glu Ser Phe Ser Ala Gly Met Asp 65 70 75 ctc aag gag tac ttc cgc gag gtc gac gcc acc ggc agc acc gcc gtg 408 Leu Lys Glu Tyr Phe Arg Glu Val Asp Ala Thr Gly Ser Thr Ala Val 80 85 90 95 cag atc aag gtg cgg cgg gcc agc gcg gag tgg cag tgg aag cgg ctg 456 Gln Ile Lys Val Arg Arg Ala Ser Ala Glu Trp Gln Trp Lys Arg Leu 100 105 110 gcg aac tgg agc aag ccg acg atc gcg atg gtc aac ggc tgg tgc ttc 504 Ala Asn Trp Ser Lys Pro Thr Ile Ala Met Val Asn Gly Trp Cys Phe 115 120 125 ggc ggc gcg ttc acc ccg ctg gtg gcc tgc gac ctg gcc ttc gcc gac 552 Gly Gly Ala Phe Thr Pro Leu Val Ala Cys Asp Leu Ala Phe Ala Asp 130 135 140 gag gac gcg cgg ttc ggg ctg tcc gag gtc aac tgg ggc atc ccg ccg 600 Glu Asp Ala Arg Phe Gly Leu Ser Glu Val Asn Trp Gly Ile Pro Pro 145 150 155 ggc ggc gtg gtc agc cgg gcg ctg gcg gcg acc gtg ccg cag cgc gac 648 Gly Gly Val Val Ser Arg Ala Leu Ala Ala Thr Val Pro Gln Arg Asp 160 165 170 175 gcg ctg tac tac atc atg acc ggt gag ccc ttc gac ggc ccg ccg cgc 696 Ala Leu Tyr Tyr Ile Met Thr Gly Glu Pro Phe Asp Gly Pro Pro Arg 180 185 190 gcg gag atg cgc ctg gtc aac gag gcg ctg ccc gcc gac cgg ctg cgg 744 Ala Glu Met Arg Leu Val Asn Glu Ala Leu Pro Ala Asp Arg Leu Arg 195 200 205 gag cgc acc cgc gag gtg gcg ctg aag ctc gcg tcg atg aac cag gtg 792 Glu Arg Thr Arg Glu Val Ala Leu Lys Leu Ala Ser Met Asn Gln Val 210 215 220 gtc ctg cac gcg gcc aag acc ggg tac aag atc gcc cag gag atg ccc 840 Val Leu His Ala Ala Lys Thr Gly Tyr Lys Ile Ala Gln Glu Met Pro 225 230 235 tgg gag cag gcc gag gac tac ctc tac gcc aag ctc gac cag tcc cag 888 Trp Glu Gln Ala Glu Asp Tyr Leu Tyr Ala Lys Leu Asp Gln Ser Gln 240 245 250 255 ttc gcc gac aag gcg ggc gcc cgc gcc aag ggg ctg acc cag ttc ctc 936 Phe Ala Asp Lys Ala Gly Ala Arg Ala Lys Gly Leu Thr Gln Phe Leu 260 265 270 gac cag aag tcc tac cgg ccc ggc ctg agc gcc ttc gac ccg gag aag 984 Asp Gln Lys Ser Tyr Arg Pro Gly Leu Ser Ala Phe Asp Pro Glu Lys 275 280 285 ta gtg cgc aac cag ggt ctg ggc tcc tgg ccg gtg cgc cgc gcc agg 1031 Val Arg Asn Gln Gly Leu Gly Ser Trp Pro Val Arg Arg Ala Arg 290 295 300 atg agc ccg cac gcg aca gcc gtc cgg cac ggc ggg acg gcg ctg acc 1079 Met Ser Pro His Ala Thr Ala Val Arg His Gly Gly Thr Ala Leu Thr 305 310 315 tac gcc gag ctg tcc cgc cgc gtc gcg cgg ctc gcc aac ggg ctg cgg 1127 Tyr Ala Glu Leu Ser Arg Arg Val Ala Arg Leu Ala Asn Gly Leu Arg 320 325 330 gcc gcc ggg gtc cgc ccc ggc gac cgg gtg gcc tac ctc ggg ccg aac 1175 Ala Ala Gly Val Arg Pro Gly Asp Arg Val Ala Tyr Leu Gly Pro Asn 335 340 345 350 cac ccg gcc tac ctg gag acc ctg ttc gcg tgc ggg cag gcc ggc gcg 1223 His Pro Ala Tyr Leu Glu Thr Leu Phe Ala Cys Gly Gln Ala Gly Ala 355 360 365 gtg ttc gtg ccg ctg aac ttc cgg ctg ggc gtc ccg gaa ctg gac cac 1271 Val Phe Val Pro Leu Asn Phe Arg Leu Gly Val Pro Glu Leu Asp His 370 375 380 gcg ctg gcc gac tcc ggc gcg tcg gtc ctt atc cac acc ccg gag cac 1319 Ala Leu Ala Asp Ser Gly Ala Ser Val Leu Ile His Thr Pro Glu His 385 390 395 gcg gag acg gtc gcg gcg ctc gcc gcc ggc cgg ctg ctg cgc gtg ccc 1367 Ala Glu Thr Val Ala Ala Leu Ala Ala Gly Arg Leu Leu Arg Val Pro 400 405 410 gcg ggc gag ctg gac gcc gcg gac gac gag ccg ccc gac ctg ccc gtc 1415 Ala Gly Glu Leu Asp Ala Ala Asp Asp Glu Pro Pro Asp Leu Pro Val 415 420 425 430 ggc ctc gac gac gtg tgc ctg ctg atg tac acc tcg ggc agc acc gga 1463 Gly Leu Asp Asp Val Cys Leu Leu Met Tyr Thr Ser Gly Ser Thr Gly 435 440 445 cgc ccc aag ggc gcg atg ctc acc cac ggc aac ctc acc tgg aac tgc 1511 Arg Pro Lys Gly Ala Met Leu Thr His Gly Asn Leu Thr Trp Asn Cys 450 455 460 gtc aac gtc ctg gtg gag acc gac ctg gcg agc gac gag cgg gca ctg 1559 Val Asn Val Leu Val Glu Thr Asp Leu Ala Ser Asp Glu Arg Ala Leu 465 470 475 gtc gcc gcg ccg ctg ttc cac gcc gcc gcg ctc ggc atg gtg tgc ctg 1607 Val Ala Ala Pro Leu Phe His Ala Ala Ala Leu Gly Met Val Cys Leu 480 485 490 ccc acc ctg ctc aag ggc ggc acg gtg atc ctg cac tcc gcg ttc gac 1655 Pro Thr Leu Leu Lys Gly Gly Thr Val Ile Leu His Ser Ala Phe Asp 495 500 505 510 ccc ggc gcc gtg ctg tcc gcg gtg gaa cag gag cgg gtc acg ctc gtg 1703 Pro Gly Ala Val Leu Ser Ala Val Glu Gln Glu Arg Val Thr Leu Val 515 520 525 ttc ggc gtg ccc acg atg tac cag gcg atc gcc gcg cac ccg cgg tgg 1751 Phe Gly Val Pro Thr Met Tyr Gln Ala Ile Ala Ala His Pro Arg Trp 530 535 540 cgc agc gcc gac ctg tcc agc ctg cgg acc ctg ctg tgc ggc ggc gcg 1799 Arg Ser Ala Asp Leu Ser Ser Leu Arg Thr Leu Leu Cys Gly Gly Ala 545 550 555 ccg gtg ccc gcc gac ctc gcc agc cgc tac ctc gac cgc ggg ctc gcg 1847 Pro Val Pro Ala Asp Leu Ala Ser Arg Tyr Leu Asp Arg Gly Leu Ala 560 565 570 ttc gtg cag ggc tac ggc atg acc gag gcc gcg ccg ggc gtg ctg gtc 1895 Phe Val Gln Gly Tyr Gly Met Thr Glu Ala Ala Pro Gly Val Leu Val 575 580 585 590 ctc gac cgc gcg cac gtc gcg gag aag atc ggc tcc gcc ggg gtg ccc 1943 Leu Asp Arg Ala His Val Ala Glu Lys Ile Gly Ser Ala Gly Val Pro 595 600 605 tcg ttc ttc acc gac gtg cgg ctg gcc ggc ccg tcc ggc gag ccg gtg 1991 Ser Phe Phe Thr Asp Val Arg Leu Ala Gly Pro Ser Gly Glu Pro Val 610 615 620 ccg ccg ggg gag aag ggc gag atc gtg gtc agc ggg ccc aac gtg atg 2039 Pro Pro Gly Glu Lys Gly Glu Ile Val Val Ser Gly Pro Asn Val Met 625 630 635 aag ggc tac tgg ggc agg ccg gag gcg acc gcc gag gtg ctg cgc gac 2087 Lys Gly Tyr Trp Gly Arg Pro Glu Ala Thr Ala Glu Val Leu Arg Asp 640 645 650 ggg tgg ttc cac tcc ggc gac gtg gcc acc gtg gac ggc gac ggg tac 2135 Gly Trp Phe His Ser Gly Asp Val Ala Thr Val Asp Gly Asp Gly Tyr 655 660 665 670 ttc cac gtc gtc gac cgg ctc aag gac atg atc atc tcc ggc ggc gag 2183 Phe His Val Val Asp Arg Leu Lys Asp Met Ile Ile Ser Gly Gly Glu 675 680 685 aac atc tac ccg gcc gag gtg gag aac gag ctg tac ggc tac ccg ggt 2231 Asn Ile Tyr Pro Ala Glu Val Glu Asn Glu Leu Tyr Gly Tyr Pro Gly 690 695 700 gtg gag gcg tgc gcc gtg atc ggc gtg ccg gac ccg cgc tgg ggc gag 2279 Val Glu Ala Cys Ala Val Ile Gly Val Pro Asp Pro Arg Trp Gly Glu 705 710 715 gtg ggc aag gcg gtc gtc gtg ccc gcc gac ggg agc cgc atc gac ggc 2327 Val Gly Lys Ala Val Val Val Pro Ala Asp Gly Ser Arg Ile Asp Gly 720 725 730 gac gag ctg ctg gcc tgg ctg cgc acc cgg ctg gcc ggg tac aag gtg 2375 Asp Glu Leu Leu Ala Trp Leu Arg Thr Arg Leu Ala Gly Tyr Lys Val 735 740 745 750 ccc aag tcg gtc gag ttc acc gac cgg ctg ccc acg acc ggc tcc ggc 2423 Pro Lys Ser Val Glu Phe Thr Asp Arg Leu Pro Thr Thr Gly Ser Gly 755 760 765 aag atc ctc aag ggc gag gtc cgc cgc cgc ttc ggc tgaccagggg 2469 Lys Ile Leu Lys Gly Glu Val Arg Arg Arg Phe Gly 770 775 ccgatgaacc ccgctcatgc ggccctgccg gcccgctgcg gctactctgt g 2520 2 287 PRT Amycolatopsis sp. 2 Met Ser Thr Ala Val Gly Asn Gly Arg Val Arg Thr Glu Pro Trp Gly 1 5 10 15 Glu Thr Val Leu Val Glu Phe Asp Glu Gly Ile Ala Trp Val Met Leu 20 25 30 Asn Arg Pro Asp Lys Arg Asn Ala Met Asn Pro Thr Leu Asn Asp Glu 35 40 45 Met Val Arg Val Leu Asp His Leu Glu Gly Asp Asp Arg Cys Arg Val 50 55 60 Leu Val Leu Thr Gly Ala Gly Glu Ser Phe Ser Ala Gly Met Asp Leu 65 70 75 80 Lys Glu Tyr Phe Arg Glu Val Asp Ala Thr Gly Ser Thr Ala Val Gln 85 90 95 Ile Lys Val Arg Arg Ala Ser Ala Glu Trp Gln Trp Lys Arg Leu Ala 100 105 110 Asn Trp Ser Lys Pro Thr Ile Ala Met Val Asn Gly Trp Cys Phe Gly 115 120 125 Gly Ala Phe Thr Pro Leu Val Ala Cys Asp Leu Ala Phe Ala Asp Glu 130 135 140 Asp Ala Arg Phe Gly Leu Ser Glu Val Asn Trp Gly Ile Pro Pro Gly 145 150 155 160 Gly Val Val Ser Arg Ala Leu Ala Ala Thr Val Pro Gln Arg Asp Ala 165 170 175 Leu Tyr Tyr Ile Met Thr Gly Glu Pro Phe Asp Gly Pro Pro Arg Ala 180 185 190 Glu Met Arg Leu Val Asn Glu Ala Leu Pro Ala Asp Arg Leu Arg Glu 195 200 205 Arg Thr Arg Glu Val Ala Leu Lys Leu Ala Ser Met Asn Gln Val Val 210 215 220 Leu His Ala Ala Lys Thr Gly Tyr Lys Ile Ala Gln Glu Met Pro Trp 225 230 235 240 Glu Gln Ala Glu Asp Tyr Leu Tyr Ala Lys Leu Asp Gln Ser Gln Phe 245 250 255 Ala Asp Lys Ala Gly Ala Arg Ala Lys Gly Leu Thr Gln Phe Leu Asp 260 265 270 Gln Lys Ser Tyr Arg Pro Gly Leu Ser Ala Phe Asp Pro Glu Lys 275 280 285 3 491 PRT Amycolatopsis sp. 3 Val Arg Asn Gln Gly Leu Gly Ser Trp Pro Val Arg Arg Ala Arg Met 1 5 10 15 Ser Pro His Ala Thr Ala Val Arg His Gly Gly Thr Ala Leu Thr Tyr 20 25 30 Ala Glu Leu Ser Arg Arg Val Ala Arg Leu Ala Asn Gly Leu Arg Ala 35 40 45 Ala Gly Val Arg Pro Gly Asp Arg Val Ala Tyr Leu Gly Pro Asn His 50 55 60 Pro Ala Tyr Leu Glu Thr Leu Phe Ala Cys Gly Gln Ala Gly Ala Val 65 70 75 80 Phe Val Pro Leu Asn Phe Arg Leu Gly Val Pro Glu Leu Asp His Ala 85 90 95 Leu Ala Asp Ser Gly Ala Ser Val Leu Ile His Thr Pro Glu His Ala 100 105 110 Glu Thr Val Ala Ala Leu Ala Ala Gly Arg Leu Leu Arg Val Pro Ala 115 120 125 Gly Glu Leu Asp Ala Ala Asp Asp Glu Pro Pro Asp Leu Pro Val Gly 130 135 140 Leu Asp Asp Val Cys Leu Leu Met Tyr Thr Ser Gly Ser Thr Gly Arg 145 150 155 160 Pro Lys Gly Ala Met Leu Thr His Gly Asn Leu Thr Trp Asn Cys Val 165 170 175 Asn Val Leu Val Glu Thr Asp Leu Ala Ser Asp Glu Arg Ala Leu Val 180 185 190 Ala Ala Pro Leu Phe His Ala Ala Ala Leu Gly Met Val Cys Leu Pro 195 200 205 Thr Leu Leu Lys Gly Gly Thr Val Ile Leu His Ser Ala Phe Asp Pro 210 215 220 Gly Ala Val Leu Ser Ala Val Glu Gln Glu Arg Val Thr Leu Val Phe 225 230 235 240 Gly Val Pro Thr Met Tyr Gln Ala Ile Ala Ala His Pro Arg Trp Arg 245 250 255 Ser Ala Asp Leu Ser Ser Leu Arg Thr Leu Leu Cys Gly Gly Ala Pro 260 265 270 Val Pro Ala Asp Leu Ala Ser Arg Tyr Leu Asp Arg Gly Leu Ala Phe 275 280 285 Val Gln Gly Tyr Gly Met Thr Glu Ala Ala Pro Gly Val Leu Val Leu 290 295 300 Asp Arg Ala His Val Ala Glu Lys Ile Gly Ser Ala Gly Val Pro Ser 305 310 315 320 Phe Phe Thr Asp Val Arg Leu Ala Gly Pro Ser Gly Glu Pro Val Pro 325 330 335 Pro Gly Glu Lys Gly Glu Ile Val Val Ser Gly Pro Asn Val Met Lys 340 345 350 Gly Tyr Trp Gly Arg Pro Glu Ala Thr Ala Glu Val Leu Arg Asp Gly 355 360 365 Trp Phe His Ser Gly Asp Val Ala Thr Val Asp Gly Asp Gly Tyr Phe 370 375 380 His Val Val Asp Arg Leu Lys Asp Met Ile Ile Ser Gly Gly Glu Asn 385 390 395 400 Ile Tyr Pro Ala Glu Val Glu Asn Glu Leu Tyr Gly Tyr Pro Gly Val 405 410 415 Glu Ala Cys Ala Val Ile Gly Val Pro Asp Pro Arg Trp Gly Glu Val 420 425 430 Gly Lys Ala Val Val Val Pro Ala Asp Gly Ser Arg Ile Asp Gly Asp 435 440 445 Glu Leu Leu Ala Trp Leu Arg Thr Arg Leu Ala Gly Tyr Lys Val Pro 450 455 460 Lys Ser Val Glu Phe Thr Asp Arg Leu Pro Thr Thr Gly Ser Gly Lys 465 470 475 480 Ile Leu Lys Gly Glu Val Arg Arg Arg Phe Gly 485 490 

1. An enzyme from Amycolatopsis sp. for the synthesis of vanillin from ferulic acid.
 2. The enzyme as claimed in claim 1, selected from the group of feruloyl-CoA synthetases or enoyl-CoA hydratase/aldolases.
 3. The enzyme as claimed in claims 1 and 2, which exerts feruloyl-CoA synthetase activity and comprises an amino acid sequence which is at least 70% identical to a sequence according to SEQ ID NO: 2 over a distance of at least 20 consecutive amino acids.
 4. The enzyme as claimed in claims 1 and 2, which exerts enoyl-CoA hydratase/aldolase activity and comprises an amino acid sequence which is at least 70% identical to a sequence according to SEQ ID NO: 3 over a distance of at least 20 consecutive amino acids.
 5. A nucleic acid comprising a nucleotide sequence which codes for an enzyme as claimed in claims 1 to 4 and functional equivalents thereof.
 6. The nucleic acid as claimed in claim 5, characterized in that it is single-stranded or double-stranded DNA or RNA.
 7. The nucleic acid as claimed in claims 5 and 6, characterized in that it is fragments of genomic DNA or cDNA.
 8. The nucleic acid as claimed in claims 5 to 7, characterized in that the nucleotide sequence corresponds to a sequence according to SEQ ID NO: 1 over a distance of at least 20 nucleotides of at least 70% identity.
 9. A DNA construct comprising a nucleic acid as claimed in any of claims 5 to 8 and a heterologous promoter.
 10. A vector comprising a nucleic acid as claimed in any of claims 5 to 8 or a DNA construct as claimed in claim
 9. 11. A cosmid clone, comprising a nucleic acid as claimed in any of claims 5 to
 9. 12. A host cell, comprising a nucleic acid as claimed in any of claims 5 to 8 or a DNA construct as claimed in claim 9 or
 10. 13. The host cell as claimed in claim 12, characterized in that it is a prokaryotic cell.
 14. The host cell as claimed in claim 13, characterized in that it is Escherichia coli.
 15. The host cell as claimed in claim 12, characterized in that it is a eukaryotic cell.
 16. The host cell as claimed in claim 15, characterized in that it is a unicellularly or filamentously growing fungus.
 17. The host cell as claimed in claim 15, characterized in that it is a plant cell.
 18. A method for preparing an enzyme as claimed in claims 1 to 4, characterized in, comprising a) culturing a host cell as claimed in any of claims 12 to 17 under conditions which ensure expression of the nucleic acid as claimed in any of claims 5 to 7, or b) expressing a nucleic acid as claimed in any of claims 5 to 11 in an in-vitro system, and c) obtaining the enzyme from the cell, the culture medium or the in-vitro system.
 19. A method for preparing feruloyl-coenzymeA from ferulic acid, characterized in that the reaction takes place in the presence of feruloyl-CoA synthetase.
 20. A method for preparing 4-hydroxy-3-methoxyphenyl-β-hydroxypropionyl-coenzymeA, characterized in that the reaction takes place in the presence of enoyl-CoA hydratase/aldolase.
 21. A method for preparing vanillin from 4-hydroxy-3-methoxyphenyl-β-hydroxypropionyl-coenzymeA, characterized in that the reaction takes place in the presence of enoyl-CoA hydratase/aldolase. 